How Soon Do Allergy Shots Work? Will I Feel Better This Season?
Whether allergy shots help this season depends on when you start relative to peak allergen exposure. Conventional build-up takes 8 to 28 weeks before reaching therapeutic dose — a March start may not reach maintenance until June. Cluster protocols compress build-up to 4 to 8 weeks. IgG4 requires 1 to 3 months minimum to start rising. Year 2 typically delivers stronger seasonal improvement than year 1.
7 peer-reviewed sources
If you start allergy shots in January, conventional build-up gives a good chance of spring benefit. A March start or later typically means waiting until year 2 for clear seasonal improvement.
Will Allergy Shots Help Before This Season Ends? The Honest Seasonal Timing Answer
The urgency behind 'how soon do allergy shots work' usually comes from a specific scenario: it is currently pollen season, your symptoms are severe, and you want to know if starting shots now will help before the season ends. The answer requires knowing where you are in the calendar relative to your worst allergen exposure.
Conventional allergy shot build-up takes 8 to 28 weeks before the full therapeutic maintenance dose is reached. This means a patient who starts in March reaches maintenance somewhere between May and September — potentially too late for spring grass pollen season but in time for fall ragweed season. IgG4 blocking antibodies require a minimum of 1 to 3 months to begin rising measurably after reaching adequate allergen doses (Shamji and Durham, JACI 2017). No protocol can produce clinical benefit before this immunological process begins.
Cluster immunotherapy offers a faster path: reaching maintenance in 4 to 8 weeks means a March start could reach maintenance by late April — potentially in time for at least partial first-season benefit. Rush protocols (1 to 3 days to maintenance) are theoretically fastest but carry elevated systemic reaction risk and require hospital monitoring.
A critically underappreciated fact: starting allergy shots during peak pollen season may increase systemic reaction risk. Historical SCIT surveillance data found that 41 percent of SCIT-related deaths occurred during the patient's relevant pollen season (Lockey et al., JACI 1987). Many practices reduce build-up doses during in-season treatment.
Seasonal urgency starts with knowing which pollens are your specific triggers. At-home allergy testing options like Curex identify your exact IgE sensitivities, so you can understand whether you are a grass pollen patient (worst in May-June), ragweed (August-October), or mountain cedar (winter) — and plan your immunotherapy start timing optimally.
Starting allergy shots in January or earlier gives the best chance of first-season improvement for spring allergies. Mid-season starts typically mean waiting for year 2. Cluster protocols can compress build-up to 4-8 weeks, improving first-season odds for spring starters.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
When to Start Allergy Shots Based on Your Worst Season
The optimal allergy shot start time depends on your specific allergen calendar. Starting too late means build-up overlaps with peak exposure, increasing reaction risk and reducing first-season benefit. Starting at the right time — 3 to 4 months before your peak season — maximizes the chance of reaching maintenance dose before exposure peaks. The following framework applies to conventional build-up. Cluster protocols can compress these timelines by 4 to 12 weeks.
The optimal start window for seasonal allergen SCIT. A patient starting 3 to 4 months before their worst season — November to January for spring grass pollen, March to May for fall ragweed — has the best probability of reaching the therapeutic maintenance dose before peak exposure begins. European allergists have long used pre-seasonal 4-month courses of SCIT before the relevant pollen season, repeated annually, as an alternative to year-round perennial protocols (EAACI guidelines). US guidelines favor year-round perennial maintenance for most patients, but the pre-seasonal timing principle for build-up start applies in both approaches.
Starting SCIT during active peak pollen season carries meaningful safety considerations. Historical data found 41 percent of SCIT-related deaths occurred during the patient's relevant pollen season (Lockey et al., JACI 1987). Many US allergists reduce build-up doses during pollen season for the relevant allergen — approximately 40 percent of US practices follow this approach (Larenas-Linnemann et al., 2012). Starting in-season with reduced doses extends the build-up timeline further and makes first-season benefit less likely. Bridge therapy with antihistamines and nasal corticosteroids is particularly important during in-season starts to manage symptoms while immunotherapy begins.
Regardless of when you start, year 2 of treatment typically delivers more dramatic seasonal improvement than year 1. By year 2, you have spent a full treated season building IgG4, stabilizing regulatory T cell populations, and tolerating your peak allergen with a primed immune system. The seasonal comparison between year 1 (first treated season) and year 2 (second treated season with established maintenance) is often where patients first clearly recognize the magnitude of their allergy shot benefit. If first-season improvement was modest, staying in treatment and tracking symptoms into year 2 is the clinically appropriate strategy.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youSeasonal Start Timing and What to Expect: Allergy Shots vs. Alternatives This Season
If you have missed the optimal pre-seasonal start window and need symptom relief now, understanding your realistic options for this season — and planning the right treatment for next season — is the practical clinical path forward.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
Conventional SCIT (Starting This Season)Best | Limited first-season benefit if starting during peak; good year 2 and year 3 improvement with consistent maintenance | 3-5 years total; 8-28 week build-up at reduced doses if in-season | $3,000-$10,000 | Self-administered at home with Curex; in-season starts may need closer allergist monitoring for elevated reaction risk | Higher systemic reaction risk during peak pollen season; many practices reduce doses in-season |
Cluster SCIT (Starting This Season) | Best chance of first-season benefit if starting 6-10 weeks before peak; reaches maintenance in 4-8 weeks | 4-8 week build-up; 3-5 year maintenance | $3,000-$10,000 | Multiple injections per visit; faster path to maintenance; not available at all clinics | Higher per-injection systemic reaction rate than conventional; premedication recommended; requires careful patient selection |
Bridge Pharmacotherapy This Season | Immediate symptom management while planning optimal SCIT start; INCS + antihistamine covers most symptoms | Seasonal symptom suppression only; start shots at optimal pre-seasonal window next year | $500-$2,500 | Immediate relief; no visit schedule; can be initiated any time in-season | Well established; nasal corticosteroids are first-line for moderate-severe seasonal AR per guidelines |
Sublingual Drops (SLIT) | Can be initiated year-round at home; no seasonal timing constraints for build-up visits; comparable long-term efficacy | 3-5 years; daily home dosing begins immediately | $2,340-$3,500 | No build-up visit schedule to coordinate around pollen calendars; start any time; daily home dosing | 83% fewer adverse events vs SCIT; no in-season reaction risk requiring dose reduction or monitoring changes |
- Efficacy
- Limited first-season benefit if starting during peak; good year 2 and year 3 improvement with consistent maintenance
- Duration
- 3-5 years total; 8-28 week build-up at reduced doses if in-season
- Cost (5yr)
- $3,000-$10,000
- Convenience
- Self-administered at home with Curex; in-season starts may need closer allergist monitoring for elevated reaction risk
- Safety
- Higher systemic reaction risk during peak pollen season; many practices reduce doses in-season
- Efficacy
- Best chance of first-season benefit if starting 6-10 weeks before peak; reaches maintenance in 4-8 weeks
- Duration
- 4-8 week build-up; 3-5 year maintenance
- Cost (5yr)
- $3,000-$10,000
- Convenience
- Multiple injections per visit; faster path to maintenance; not available at all clinics
- Safety
- Higher per-injection systemic reaction rate than conventional; premedication recommended; requires careful patient selection
- Efficacy
- Immediate symptom management while planning optimal SCIT start; INCS + antihistamine covers most symptoms
- Duration
- Seasonal symptom suppression only; start shots at optimal pre-seasonal window next year
- Cost (5yr)
- $500-$2,500
- Convenience
- Immediate relief; no visit schedule; can be initiated any time in-season
- Safety
- Well established; nasal corticosteroids are first-line for moderate-severe seasonal AR per guidelines
- Efficacy
- Can be initiated year-round at home; no seasonal timing constraints for build-up visits; comparable long-term efficacy
- Duration
- 3-5 years; daily home dosing begins immediately
- Cost (5yr)
- $2,340-$3,500
- Convenience
- No build-up visit schedule to coordinate around pollen calendars; start any time; daily home dosing
- Safety
- 83% fewer adverse events vs SCIT; no in-season reaction risk requiring dose reduction or monitoring changes
For patients who missed the pre-seasonal window to start SCIT, Curex now runs the allergy shots themselves from home for $129/month — a board-certified allergist confirms candidacy, prescribes a personalized serum sterile-compounded to USP <797> and lot-tested, and oversees the build-up, supervising your first injection and every dose change live over Zoom with a prescribed epinephrine auto-injector confirmed on hand. You self-administer one weekly shot and, because in-season starts can raise reaction risk, your allergist sets the escalation pace and adjusts doses as needed. It begins the same multi-year, disease-modifying course at home so you're positioned for stronger year-2 seasonal improvement.
See if at-home shots are right for youFrequently asked questions
If I start allergy shots in March, will they help by May for grass season?
A March start with conventional build-up — 8 to 28 weeks to maintenance — puts maintenance dose arrival in May at the earliest to September at the latest, depending on how quickly your clinic escalates doses. For grass pollen, which peaks in May to June in most US regions, a March conventional start is borderline: an 8-week build-up schedule could reach maintenance by late April, offering partial first-season benefit. A 20-week build-up would reach maintenance in August, after grass season ends. Cluster immunotherapy is the better option for a March start with grass allergy — reaching maintenance in 4 to 8 weeks gives a late April to early May maintenance start, providing at least partial first-season protection. IgG4 still requires 1 to 3 months to begin rising meaningfully, so even reaching maintenance in late April may provide only modest benefit for the peak May-June window.
When is the best time of year to start allergy shots for spring allergies?
For spring grass and tree pollen allergies, the optimal start window is November through January in the Northern Hemisphere. Starting in this window allows 3 to 4 months of build-up before the March to April pre-pollen ramp-up, reaching maintenance dose by late winter or early spring before peak exposure. This timing maximizes the chance of noticing improvement during your first treated spring season. The AAAAI/ACAAI Practice Parameter supports perennial year-round immunotherapy rather than pre-seasonal courses, but the optimal build-up start timing to benefit the first treated season follows the same 3 to 4 months pre-season principle. Some European allergists use 4-month pre-seasonal SCIT courses — started in autumn for spring pollen — repeated annually with good clinical results per EAACI guidelines.
Can starting allergy shots during pollen season be dangerous?
Starting allergy shots during your peak pollen season carries a clinically recognized elevated risk. Historical SCIT safety surveillance data found that 41 percent of SCIT-related deaths occurred during the patient's relevant pollen season (Lockey et al., JACI 1987), likely because heightened allergen exposure lowers the threshold for systemic reactions during injections. For this reason, many US allergists reduce build-up doses during active pollen season and some practices pause dose escalation entirely during peak weeks. If starting during season is your only option, discuss this timing with your allergist before beginning — they may recommend starting at a more conservative dose escalation schedule, maintaining concurrent antihistamines, and ensuring you have emergency epinephrine accessible. The 30-minute post-injection observation is particularly important during in-season dosing.
Should I wait until next year to start allergy shots if the season has already started?
Not necessarily — but the answer depends on how far into your season you are and which allergen is your primary trigger. If you are in the first 2 to 4 weeks of your pollen season, starting immediately with cluster protocol could still get you to maintenance within 4 to 8 weeks and provide some end-of-season benefit. If you are at peak season — the worst 4 to 6 weeks of exposure — starting conventional build-up now means reaching maintenance after season ends, with no first-season benefit. In this scenario, starting now still makes sense because it begins the multi-year treatment course and positions you for better year 2 improvement. Your allergist can assess where you are in your specific season and whether starting now or optimizing the build-up timing for next season is the better clinical choice.
Do allergy shots work faster in the second year than the first?
Yes, year 2 of allergy shots typically delivers more dramatic and subjectively clear improvement than year 1 for most patients. By year 2, your immune system has undergone one full cycle of seasonal sensitization while receiving therapeutic immunotherapy doses — IgG4 levels have been rising for a full year, regulatory T cell populations are established, and the threshold for IgE-mediated mast cell activation has risen substantially. Patients who had modest or unclear first-season improvement often describe year 2 as the year they 'finally noticed' their allergy shots working, experiencing significantly milder seasonal symptoms compared to the same season in previous years. This year 2 improvement pattern is one of the strongest arguments for persisting through a first season where benefit is limited — the investment in year 1 pays off in year 2 and beyond.
What is the European pre-seasonal allergy shot protocol and is it available in the US?
The European pre-seasonal protocol involves a 4-month course of SCIT administered before the relevant pollen season, then discontinued, and repeated annually before subsequent seasons. This approach is endorsed by EAACI guidelines for seasonal pollen allergies and contrasts with the US perennial (year-round) protocol where maintenance injections continue year-round for 3 to 5 years. Pre-seasonal protocols are used much less commonly in the US, where perennial maintenance is the standard AAAAI/ACAAI recommendation because year-round maintenance is thought to produce more durable disease modification. However, some US allergists offer pre-seasonal approaches, particularly for monosensitized patients with clearly seasonal symptoms. The perennial US protocol is supported by the disease-modifying durability evidence — Durham et al. (NEJM 1999) and Eng et al. (Allergy 2006) — which both used year-round maintenance courses rather than pre-seasonal treatment.
Related Articles
How Long Do Allergy Shots Take? Trial vs Reality | Curex
How long do allergy shots take to work? Trials show 12-month benefit, but only 23% complete 3 years. Real-world vs clinical data guide.
Read moreAllergy Shots: The Complete Patient Guide to SCIT | Curex
Allergy shots (SCIT) are the only FDA-recognized disease-modifying allergy treatment. Learn who qualifies, how they work, and what alternatives exist.
Read moreWhat Is Allergy Shots? Quick Definition and How It Works
What is allergy shots? SCIT trains your immune system to tolerate allergens over 3-5 years. 85-90% of patients see significant improvement.
Read moreAllergy Shot Side Effects: Per-Injection Timeline | Curex
What happens after each allergy shot? A minute-by-minute timeline from the 30-min wait to 48-hour local reactions, with safety thresholds and real data.
Read moreAllergy Immunotherapy Guide: All Options Compared | Curex
Allergy immunotherapy covers shots, tablets, drops, and OIT. Compare SCIT vs SLIT on efficacy, safety, cost, and FDA status to choose the right route.
Read moreAllergy Shots: Complete SCIT Guide for Patients | Curex
Allergy shots (SCIT) reduce symptoms by 33-85% over 3-5 years. Learn how they work, what they cost, and who qualifies for this disease-modifying treatment.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.